Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dalpiciclib
Sponsor: Hebei Medical University Fourth Hospital